Campbell & CO Investment Adviser LLC Makes New Investment in STERIS plc (NYSE:STE)

Campbell & CO Investment Adviser LLC purchased a new stake in STERIS plc (NYSE:STEFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 1,881 shares of the medical equipment provider’s stock, valued at approximately $414,000.

Several other hedge funds have also recently modified their holdings of the business. Janney Montgomery Scott LLC lifted its holdings in STERIS by 4.6% during the third quarter. Janney Montgomery Scott LLC now owns 20,576 shares of the medical equipment provider’s stock worth $4,515,000 after buying an additional 903 shares during the period. Van ECK Associates Corp lifted its stake in shares of STERIS by 13.4% during the 3rd quarter. Van ECK Associates Corp now owns 12,042 shares of the medical equipment provider’s stock worth $2,642,000 after purchasing an additional 1,424 shares during the last quarter. Pathstone Family Office LLC boosted its position in STERIS by 62.4% during the third quarter. Pathstone Family Office LLC now owns 7,904 shares of the medical equipment provider’s stock valued at $1,734,000 after purchasing an additional 3,037 shares in the last quarter. UBS Group AG raised its holdings in STERIS by 17.1% in the third quarter. UBS Group AG now owns 143,822 shares of the medical equipment provider’s stock worth $31,557,000 after purchasing an additional 21,024 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in shares of STERIS by 14.6% during the third quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,836 shares of the medical equipment provider’s stock valued at $4,352,000 after buying an additional 2,521 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Insider Transactions at STERIS

In related news, Director Jacqueline B. Kosecoff sold 4,584 shares of the business’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $231.53, for a total transaction of $1,061,333.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other STERIS news, SVP Cary L. Majors sold 2,024 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $232.13, for a total value of $469,831.12. Following the sale, the senior vice president now owns 11,369 shares in the company, valued at approximately $2,639,085.97. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Jacqueline B. Kosecoff sold 4,584 shares of STERIS stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $231.53, for a total transaction of $1,061,333.52. The disclosure for this sale can be found here. Insiders have sold 7,762 shares of company stock worth $1,798,477 over the last 90 days. 0.95% of the stock is currently owned by company insiders.

STERIS Stock Performance

Shares of STE stock opened at $224.77 on Tuesday. The business has a fifty day moving average of $216.99 and a 200 day moving average of $219.44. STERIS plc has a 1 year low of $195.47 and a 1 year high of $254.00. The company has a debt-to-equity ratio of 0.49, a current ratio of 3.08 and a quick ratio of 2.36. The firm has a market capitalization of $22.23 billion, a price-to-earnings ratio of 58.84 and a beta of 0.85.

STERIS (NYSE:STEGet Free Report) last announced its quarterly earnings data on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $2.41 by $0.17. STERIS had a return on equity of 13.73% and a net margin of 6.95%. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period in the prior year, the company earned $2.30 earnings per share. The company’s revenue was up 10.8% on a year-over-year basis. As a group, research analysts expect that STERIS plc will post 9.24 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 0.93%. The ex-dividend date is Wednesday, June 12th. STERIS’s dividend payout ratio (DPR) is currently 54.45%.

Wall Street Analyst Weigh In

STE has been the subject of several recent analyst reports. StockNews.com upgraded shares of STERIS from a “hold” rating to a “buy” rating in a research note on Friday. JMP Securities reiterated a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, May 9th. Piper Sandler restated a “neutral” rating and set a $225.00 target price (up from $220.00) on shares of STERIS in a research note on Friday, May 10th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, May 10th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $241.60.

Check Out Our Latest Stock Analysis on STE

STERIS Company Profile

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Further Reading

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.